Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Deng, Jing Na ^a,b   Li, Juan ^c   Mu, Hong Na ^a,b   Liu, Yu Ying ^a,b   Wang, Ming Xia ^a,b   Pan, Chun Shui ^a,b   Fan, Jing Yu ^a,b   Ye, Fei ^c   Han, Jing Yan ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b State Administration of Traditional Chinese Medicine   (China)

^c INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; DEEPURE TEA EXTRACT; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEEPURE TEA; DOWN REGULATION; FATTY ACID SYNTHESIS; GLUCOSE TOLERANCE TEST; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID STORAGE; LIPOGENESIS; MALE; METABOLIC SYNDROME X; MOLECULAR MECHANICS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TEA;

EID: 84945321026     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/980345     Document Type: Article

References (38)

1. K. G. M. M. Alberti and P. Z. Zimmet, "Definition, diagnosis and classification of diabetesmellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of aWHO consultation," DiabeticMedicine, vol. 15, no. 7, pp. 539-553, 1998.
2. J. D. Browning and J. D. Horton, "Molecular mediators of hepatic steatosis and liver injury,"The Journal of Clinical Investigation, vol. 114, no. 2, pp. 147-152, 2004.
3. G. Marchesini, M. Brizi, G. Blanchi et al., "Nonalcoholic fatty liver disease: a feature of the metabolic syndrome," Diabetes, vol. 50, no. 8, pp. 1844-1850, 2001.
4. H. C. Masuoka and N. Chalasani, "Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals," Annals of the New York Academy of Sciences, vol. 1281, no. 1, pp. 106-122, 2013.
5. V. Ratziu and T. Poynard, "Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious," Hepatology, vol. 44, no. 4, pp. 802-805, 2006.
6. A. Kotronen and H. Yki-Järvinen, "Fatty liver: a novel component of the metabolic syndrome," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 27-38, 2008.
7. P. Haentjens, D. Massaad, H. Reynaert et al., "Identifying nonalcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics," Acta Clinica Belgica, vol. 64, no. 6, pp. 483-493, 2009.
8. Y. Kido, D. J. Burks, D. Withers et al., "Tissue-specific insulin resistance in mice withmutations in the insulin receptor, IRS-1, and IRS-2," The Journal of Clinical Investigation, vol. 105, no. 2, pp. 199-205, 2000.
9. D. J. Withers, J. S. Gutierrez, H. Towery et al., "Disruption of IRS-2 causes type 2 diabetes in mice," Nature, vol. 391, no. 6670, pp. 900-904, 1998.
10. I. Shimomura, Y. Bashmakov, S. Ikemoto, J. D. Horton, M. S. Brown, and J. L. Goldstein, "Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocininduced diabetes," Proceedings of theNational Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13656-13661, 1999.
11. V. T. Samuel, Z.-X. Liu, X. Qu et al., "Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease," Journal of Biological Chemistry, vol. 279, no. 31, pp. 32345-32353, 2004.
12. T. Ide, H. Shimano, N. Yahagi et al., "SREBPs suppress IRS-2- mediated insulin signalling in the liver," Nature Cell Biology, vol. 6, no. 4, pp. 351-357, 2004.
13. M. den Boer, P. J. Voshol, F. Kuipers, L.M. Havekes, and J. A. Romijn, "Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 644-649, 2004.
14. C. A. Nagle, E. L. Klett, and R. A. Coleman, "Hepatic triacylglycerol accumulation and insulin resistance," Journal of Lipid Research, vol. 50, supplement, pp. S74-S79, 2009.
15. C. Cabrera, R. Artacho, and R. Giménez, "Beneficial effects of green tea-a review," Journal of the American College of Nutrition, vol. 25, no. 2, pp. 79-99, 2006.
16. K. Kubota, S. Sumi, H. Tojo et al., "Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract," Nutrition Research, vol. 31, no. 6, pp. 421-428, 2011.
17. Z.-H. Cao, D.-H. Gu, Q.-Y. Lin et al., "Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity," Phytotherapy Research, vol. 25, no. 2, pp. 234-238, 2011.
18. Y. Shimamura, M. Yoda, H. Sakakibara, K. Matsunaga, and S. Masuda, "Pu-erh tea suppresses diet-induced body fat accumulation in C57BL/6J mice by down-regulating SREBP-1c and related molecules," Bioscience, Biotechnology and Biochemistry, vol. 77, no. 7, pp. 1455-1460, 2013.
19. X. Ma, S. Tsuda, X. Yang et al., "Pu-erh tea hot-water extract activates akt and induces insulin-independent glucose transport in rat skeletal muscle," Journal of Medicinal Food, vol. 16, no. 3, pp. 259-262, 2013.
20. S. Wang, S. K. Noh, and S. I. Koo, "Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats," The Journal of Nutrition, vol. 136, no. 11, pp. 2791-2796, 2006.
21. D. G. Raederstorff, M. F. Schlachter, V. Elste, and P. Weber, "Effect of EGCG on lipid absorption and plasma lipid levels in rats," Journal of Nutritional Biochemistry, vol. 14, no. 6, pp. 326-332, 2003.
22. R. Tao, F. Ye, Y. He et al., "Improvement of high-fat-diet-induced metabolic syndrome by a compound fromBalanophora polyandra Griff in mice," European Journal of Pharmacology, vol. 616, no. 1-3, pp. 328-333, 2009.
23. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man," Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
24. S.-Q. Lin, X.-H. Wei, P. Huang et al., "Qi Shen Yi Qi Pills prevents cardiac ischemia-reperfusion injury via energy modulation," International Journal of Cardiology, vol. 168, no. 2, pp. 967-974, 2013.
25. X. J. Sun, L.-M. Wang, Y. Zhang et al., "Role of IRS-2 in insulin and cytokine signalling," Nature, vol. 377, no. 6545, pp. 173-177, 1995.
26. J.D. Horton, J. L. Goldstein, and M. S. Brown, "SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver," Journal of Clinical Investigation, vol. 109, no.9, pp. 1125-1131, 2002.
27. S. Han, C.-P. Liang, M. Westerterp et al., "Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice," Journal of Clinical Investigation, vol. 119, no. 4, pp. 1029-1041, 2009.
28. R. Streicher, J. Kotzka, D.Müller-Wieland et al., "SREBP-1mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I," The Journal of Biological Chemistry, vol. 271, no. 12, pp. 7128-7133, 1996.
29. J. K. Kim, M. D. Michael, S. F. Previs et al., "Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle," The Journal of Clinical Investigation, vol. 105, no. 12, pp. 1791-1797, 2000.
30. G. I. Shulman, "Cellular mechanisms of insulin resistance," Journal of Clinical Investigation, vol. 106, no. 2, pp. 171-176, 2000.
31. M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo, "Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose," Diabetes Care, vol. 29, no. 5, pp. 1130-1139, 2006.
32. W.-H. Du, S.-M. Peng, Z.-H. Liu, L. Shi, L.-F. Tan, and X.-Q. Zou, "Hypoglycemic effect of the water extract of Pu-erh tea," Journal of Agricultural and Food Chemistry, vol. 60, no. 40, pp. 10126-10132, 2012.
33. I. Shimomura, M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein, "Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice," Molecular Cell, vol. 6, no. 1, pp. 77-86, 2000.
34. H. Shimano, N. Yahagi, M. Amemiya-Kudo et al., "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes," The Journal of Biological Chemistry, vol. 274, no. 50, pp. 35832-35839, 1999.
35. M. S. Brown and J. L. Goldstein, "The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor," Cell, vol. 89, no. 3, pp. 331-340, 1997.
36. J. D. Horton, "Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis," Biochemical Society Transactions, vol. 30, no. 6, pp. 1091-1095, 2002.
37. H. Gao, Z. Liu, W. Wan, X. Qu, and M. Chen, "Aqueous extract of yerba mate tea lowers atherosclerotic risk factors in a rat hyperlipidemiamodel," Phytotherapy Research, vol. 27, no. 8, pp. 1225-1231, 2013.
38. T. Murase, K. Misawa, Y. Minegishi et al., "Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice," The American Journal of Physiology-Endocrinology and Metabolism, vol. 300, no. 1, pp. E122-E133, 2011.